Following on from our CVU mini virtual event: Matters of the heart: myocarditis and pericarditis associated with COVID-19 mRNA vaccination, The Melbourne Vaccine Education Centre is excited to announce our latest resource The MVEC Conversation: myocarditis/pericarditis following mRNA vaccines. This vodcast takes a deeper look into this adverse event of special interest (AESI) and features special guest Dr. Tom Shimabukuro, the deputy director of the Immunization Safety Office at the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia, in conversation with Dr Daryl Cheng and Associate Professor Nigel Crawford.
They discuss what we can learn from the USA including how they first picked up and continue to monitor this AESI, the epidemiology of their cases, how this compares to Australian data and what they are seeing with the introduction of booster doses of COVID-19 mRNA vaccines.
To view the vodcast, please login to the MVEC Education Portal.
Presenters
Dr Daryl Cheng
MBBS, MPH, FRACP Medical Lead, Melbourne Vaccine Education Centre
Dr Cheng is a general paediatrician who works at The Royal Children’s Hospital and Monash Children’s Hospital. He is a Senior Research Fellow at Murdoch Children’s Research Institute. He has special interests in immunisation, education and health informatics.
A/Prof Nigel Crawford
Director, Surveillance of Adverse Events Following Vaccination In the Community (SAEFVIC), Victoria, Australia
Chair, Australian Technical Advisory Group on Immunisation (ATAGI)
A/Prof Associate Professor Crawford is a vaccinologist and consultant paediatrician with a strong track record in vaccine safety research. His main research activities are in the fields of vaccine safety and surveillance, COVID-19 in families and children, special risk group’s immunisation, vaccine preventable diseases epidemiology including emerging infections (RSV and invasive Group A streptococcus (iGAS)) and immunisation, and public health policy development. He is the Director of SAEFVIC (Murdoch Children’s Research Institute) and Head of Immunisation Services at The Royal Children’s Hospital. He is currently a senior medical advisor to the Victorian Department Health COVID-19 vaccine and is Chair of the Victorian Specialist Immunisation services (VicSIS). Most recently on 1st July 2021, he was appointed the new Chair of ATAGI and is also on the COVID-19 ATAGI executive and chair of Subgroup #3 which includes vaccine safety, monitoring, evaluation, communication and confidence.
Dr Tom Shimabukuro
Deputy director of the Immunization Safety Office Centers for Disease Control and Prevention (CDC)
Dr Shimabukuro is the deputy director of the Immunization Safety Office at the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia. He is currently serving as team lead for the Vaccine Safety Team in CDC’s COVID-19 Vaccine Task Force. Dr. Shimabukuro received his MD degree from New York University School of Medicine. He did his internship at Emory University School of Medicine and preventive medicine residency at the Johns Hopkins Bloomberg School of Public Health. Dr. Shimabukuro also completed a fellowship as an Epidemic Intelligence Service officer at CDC.